Home / Nervous system / Rimegepant
ATC N02CD06 · Calcitonin Gene-related Peptide (CGRP) Antagonists · updated 2 Nov 2026
Rimegepant shortage
As of 2 Nov 2026, Rimegepant has a reported shortage in 1 of the 16 countries we track (Ireland), covering 1 product from 1 company.
Is there a Rimegepant shortage?
Yes. As of 2 Nov 2026, Rimegepant is reported short in 1 of the 16 countries we track: Ireland. No company has given a return date. New since 3 Oct 2026: Ireland.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Pfizer PFE · NYSE
Compared with similar medicines
ATC group N02CD · Calcitonin Gene-related Peptide (CGRP) AntagonistsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IE | Vydura 75 mg oral lyophilisate 1 x 2 | Pfizer Europe MA EEIG | 8 Oct 2026 | not given | Increased demand Unexpected increased demand |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Rimegepant shortage?
Yes. As of 2 Nov 2026, Rimegepant is reported short in 1 of the 16 countries we track: Ireland. No company has given a return date. New since 3 Oct 2026: Ireland.
When will Rimegepant be back in stock?
No return date has been given; Ireland: no date given. These are company estimates reported to each authority.
Why is Rimegepant in short supply?
The most common reason reported is: increased demand. Reasons by product are listed in the table below.
Which companies have Rimegepant shortages?
Pfizer.